论文部分内容阅读
目的分析对冠心病合并室性心律失常患者采用稳心颗粒进行治疗的临床效果和安全性。方法 100例冠心病合并室性心律失常患者,盲选分为观察组和对照组,各50例。对照组患者采用美托洛尔治疗,观察组患者采用稳心颗粒联合美托洛尔治疗。比较两组患者治疗后24 h动态心电图疗效、临床效果以及不良反应发生情况。结果治疗后,观察组患者24 h动态心电图总有效率为90.0%,高于对照组66.0%,差异有统计学意义(P<0.05)。观察组临床有效率94.0%高于对照组的62.0%,差异有统计学意义(P<0.05)。观察组患者不良反应发生率为6.0%,低于对照组的20.0%,差异具有统计学意义(P<0.05)。结论临床上采用美托洛尔联合稳心颗粒来对冠心病合并室性心律失常进行治疗能够取得很好的效果,有效改善患者的症状,且安全系数也很高,值得进行推广。
Objective To analyze the clinical effect and safety of Wenxin Granule in patients with coronary heart disease and ventricular arrhythmia. Methods 100 cases of coronary heart disease with ventricular arrhythmia patients, blind selection was divided into observation group and control group, 50 cases each. Patients in the control group were treated with metoprolol, and those in the observation group were treated with Wenxin granules combined with metoprolol. The electrocardiogram curative effect, clinical effect and adverse reaction of 24 hours after treatment in both groups were compared. Results After treatment, the total effective rate of 24 h dynamic electrocardiogram in observation group was 90.0%, which was higher than that in control group (66.0%), the difference was statistically significant (P <0.05). The clinical effective rate in the observation group was 94.0% higher than that in the control group (62.0%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 6.0%, which was lower than that in the control group (20.0%), the difference was statistically significant (P <0.05). Conclusion The combination of Metoprolol and Wenxin Granule in clinical treatment of coronary heart disease with ventricular arrhythmia can achieve good results, effectively improve the symptoms of patients, and the safety factor is also high, it is worth promoting.